Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board

World News: . []

NEW HAVEN Conn Feb 12 2018 GLOBE NEWSWIRE -- Sven Jacobson will be the first to admit that developing a new therapeutic for spinal cord injury is a challenging road But the latest member of the ReNetX Advisory Board sees the promise of the ir firs...

More news and information about ReNetX Bio

Published By:

Globe Newswire: 15:00 GMT Monday 12th February 2018

Published: .

Search for other references to "remedy" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us